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Oxidative addition of donor-functionalised 4-iodoimidazol-
ium salts to palladium(0) provides a selective route for the
preparation of abnormal chelating N-heterocyclic carbene
complexes and enables the introduction of a variety of donor
groups. The activation of the C4 position does not necessitate
protection of the imidazolium C2 position, thereby leaving
this site available for further modification. While metallation
Introduction
Abnormal N-heterocyclic carbenes (NHCs) have remark-
ably different electronic properties from their normal NHC
analogues,[1] which has led to distinct reactivity patterns
and in some cases enhanced catalytic activity.[2] The features
responsible for the special properties of abnormal NHCs,
Scheme 1. Typical synthetic pathways to normal and abnormal imidazolylidene complexes.
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of the unsubstituted C2 position of the N-heterocyclic car-
bene ligand was unsuccessful when palladium was bound to
the C4 carbon atom, sequential metallation of first the C2
position, by means of transmetallation, followed by C4–I oxi-
dative addition, afforded a dimetallic complex comprised of
two palladium centres bridged by a single NHC ligand.
i.e. the enhanced donor capacity due to decreased hetero-
atom stabilisation, also implies that the free abnormal car-
bene is far less stable than its normal counterpart.[3] Abnor-
mal imidazolylidene complexes are therefore mostly synthe-
sised through direct or base-assisted C–H activation.[1,4]
Formation of a silver carbene complex for transmetallation
has proven problematic.[5] In order to ensure the exclusive
formation of C4-bound carbenes, the C2 position generally
needs to be substituted by an alkyl or aryl group.[6] An al-
ternative to the protection of the C2 position is the acti-
vation of the C4 position by a halide substituent, which
enables metallation by C–X oxidative addition to a low-
valent metal centre (Scheme 1). Oxidative addition of imid-
azolium salts to transition metal centres is a well-estab-
lished route for the synthesis of normal NHC complexes.[7]
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Apart from rendering metallation chemoselective, this pro-
tocol principally also allows the C2 position to be kept un-
protected and available for further functionalisation. For
example, dimetallic systems may become accessible by me-
tallation through C2–H activation. While dimetallic triazol-
diylidene complexes have been explored in depth,[8] related
dimetallic carbene/alkenyl complexes derived from imid-
azolium salts are far less known, though they have received
increasing attention recently.[9] Dimetallic complexes, espe-
cially when they are comprised of two different metals, pro-
vide interesting opportunities for catalysing tandem pro-
cesses.[10]
Expanding on our initial work,[11] we have used C4-io-
dinated imidazolium salts as NHC precursors for oxidative
addition to palladium(0) and explored the potential of in-
corporating different chelating donor groups (denoted as
“E”) as wingtip substituents, ranging from the relatively
hard –NEt2 to a comparably soft –SPh group. Preliminary
results also indicate that this approach may be useful for
the synthesis of a variety of homo- and heterodimetallic
systems.
Results and Discussion
Synthesis
4/5-Iodoimidazole, which is readily accessible through
iodination of imidazole,[12] was used as precursor to the ab-
normal NHC ligands. Selective alkylation of the remote ni-
trogen atom was achieved by using 2-iodopropane,[13] thus
yielding 4-iodo-N-isopropylimidazole. Exclusive alkylation
at N1 was demonstrated by NOESY experiments, which
unambiguously confirmed the proximity of the iPr group
to both residual imidazole protons. In contrast, alkylation
with EtI gave an approximate 3:1 mixture of the two pos-
sible isomers, i.e. N-ethyl-4- and -5-iodoimidazole. The
minor isomer exhibited nuclear Overhauser effects with a
single imidazole proton only. Apparently, the size of the io-
dide nucleus in combination with the bulk of the iPr group
provides sufficient steric congestion to induce regioselective
alkylation. Potentially chelating, functionalised wingtip
groups were introduced by N2-quaternisation of the N1-
substituted 4-iodoimidazole derivative with appropriately
functionalised alkyl halides, thus yielding the ligand precur-
sors 1–4 (Scheme 2).[14]
Oxidative addition of the imidazolium salts 1–4 to the
palladium(0) centre in Pd(dba)2 yielded abnormal NHC–
palladium(II) complexes 5–8 in unoptimised yields of 18–
60% (Scheme 2). The syntheses were carried out under inert
conditions at room temperature in CH2Cl2 or DMSO, but
all the complexes are air- and moisture-stable. Complex 8b
was obtained by treatment of 8a with NaI at room tempera-
ture.
X-ray Crystallographic Analyses
The chelating nature of the ligands in complexes 5–8 was
unambiguously confirmed by single-crystal X-ray diffrac-
Scheme 2. Synthesis of abnormal carbene complexes by oxidative
addition of imidazolium salts. Reagents and conditions: (i) Pd-
(dba)2, CH2Cl2, r.t., 12 h; (ii) Pd(dba)2, CH2Cl2, 0 °C to r.t., 2 d;
(iii) Pd(dba)2, DMSO, r.t., 2 d; (iv) Pd(dba)2, DMSO, r.t., 12 h; (v)
NaI, acetone, r.t., 16 h.
tion analyses. The molecular structure of 5 has been re-
ported previously,[11] and the structures of complexes 6, 7
and 8b are depicted in Figure 1. In all three structures the
palladium centre resides in a slightly distorted square-
planar environment comprised of the C,E-bidentate car-
bene ligand and two halides. The halides in the structures
of 6 and 7 were scrambled and their occupancies refined to
a ratio of 7:3 in 6 and 11:9 in 7.[15] In both cases the major
isomer contains the iodide cis to the NHC ligand, and the
minor isomer has a mutual trans arrangement of the NHC
group and iodido ligand. The major isomer represents the
kinetic product and is also expected to be thermodynami-
cally most stable when considering the relative trans influ-
ence (NHC  SR2  NR3 and iodide  bromide). How-
ever, the differences between I– and Br– may be sufficiently
small to account for the observed solid-state distribution
(cf. solution studies below).
The Ccarbene–Pd–E bite angle in the ethylene-linked che-
lates 6 [93.14(13)°], 7 [93.4(3)°] and 8b [93.34(12)°] is slightly
larger than the corresponding bite angle in 5 [86.7 (3)°],
reflecting the larger flexibility of the palladacycle comprised
of two sp3-hybridised carbon atoms. The imidazolylidene
ring in 6, 7 and 8b is furthermore twisted out of the metal
coordination plane by roughly 30°, while in 5 the imid-
azolylidene and pyridyl rings both form a dihedral angle of
ca. 40° with the metal coordination plane and assume a
puckered conformation.[16]
Because of the halide disorder in complexes 6 and 7, a
sensible bond-length comparison is limited to complexes 5
and 8b. The structure of 5 contained only one isomer, de-
spite the presence of two different halides, whereas halide
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Figure 1. ORTEP representation of 6 (a), 7 (b) and 8b (c). All ther-
mal ellipsoids drawn at the 50% probability level. Hydrogen atoms
and cocrystallised solvent molecules omitted for clarity.
scrambling in 8b is irrelevant.[17] The Pd–I(1) bond in 8b
[2.6350(5) Å] is significantly longer than the corresponding
bond in 5 (2.5179 Å) indicating a stronger trans influence
of the soft S(alkyl) ligand in 8b compared with the pyridyl
ligand in 5.[18] In addition, the less pronounced puckering
of the ligand in 8b may induce steric repulsion between the
iPr group and the iodido ligand. The Pd–Ccarbene bond
lengths in all the complexes fall within the range typically
observed for abnormal NHC–palladium complexes
[1.99(3) Å][2,4,19] and do not differ from related complexes
featuring a normal C2 bonding mode of the NHC li-
gand.[15,16,20] The Pd–Ccarbene bond in 8b [2.013(4) Å] is
slightly longer than in 5 [1.961(7) Å], which presumably re-
flects the different flexibility in the six-membered metallacy-
cle (cf. bite angles). The average heterocyclic C(1)–C(2)
bond length in complexes 5–8 is 1.37(3) Å, which points to
a predominantly π-conjugated system and suggests vinyl-
type bonding of the C4-bound carbene ligand.[21] In normal
NHC complexes the C–C bond length is typically around
1.33 Å, consistent with a rather localised double bond. In
addition, complexes 6 and 7 feature hydrogen bonds be-
tween the imidazolylidene C5–H, crystallographically lab-
elled C(2), and the halide in the cis position [C(2)–H···X
2.86 and 2.91 Å, respectively].[22] Furthermore, one of the
methylene protons of each NEt group in 6 is in close prox-
imity to the metal-bound halide in the cis position (C–H···X
2.86 and 2.69 Å, respectively). A hydrogen bond has pre-
viously been noted between the pyridyl C6–H and the bro-
mide atom in the cis position in complex 5.[11] Such short
contacts between the pyridyl C6–H and halide in the cis
position have also been identified in related normal NHC
complexes.[23] Selected bond lengths and angles for com-
plexes 5, 6, 7 and 8b are shown in Table 1.
Table 1. Selected bond lengths [Å] and angles [°] for complexes 5,
6, 7 and 8b.[a]
5[b] 6[b] 7[c] 8b[c]
Pd(1)–C(1) 1.961(7) 1.989(3) 1.977(9) 2.013(4)
Pd(1)–E 2.098(6) 2.160(3) 2.281(2) 2.2865(11)
C(1)–C(2) 1.393(10) 1.370(5) 1.376(13) 1.355(6)
C(1)–Pd(1)–E 86.7(3) 93.14(13) 93.4(3) 93.34(12)
[a] Data for complex 5 from ref.[11] [b] E = N(3). [c] E = S(1).
NMR Spectroscopic Studies
Palladium complex formation was evidenced in solution
by the shift of the high-field C–I carbon signal in the 13C
NMR spectrum. Furthermore, palladation induced an up-
field shift of the signals of the C2–H and C5–H protons (to
δH ≈ 8.3 and 7.2 ppm, respectively) in all complexes.[24] In
[D6]DMSO these signals appear broad in both the 1H
NMR and in particular in the 13C NMR spectra. The pro-
ton and carbon signals due to the ethylene linker and also
the signals of the chelating SPh and NEt2 groups in 6–8
were broad, in contrast to the iPr proton signals, which
were sharp. While this may indicate a degree of fluxionality
in the coordination of the nitrogen and sulfur atoms to the
palladium centre in solution (hemilability), variable-tem-
perature experiments indicated that the signals remained
broad up to 80 °C. Such natural broadening of the signals
may originate from reduced flexibility of the ligand due to
conformationally stabilised hydrogen bonding to halides (cf.
X-ray crystallographic section). This hypothesis is further
supported by a 0.73 ppm downfield shift and substantial
broadening of the pyridyl C6–H proton signal in complex
5.
In complex 6, two sets of imidazolylidene 1H NMR sig-
nals are visible in an approximate 5:1 ratio. The minor set
is broad and overlaps with the resonances of the major
component, except for the low-field resonance of the C2-
bound proton, which appears at δ = 8.90 ppm for the major
species and at δ = 8.84 ppm for the minor one. In the 13C
NMR spectrum, all resonances are broadened, and the
minor isomer was not detected. The presence of two com-
pounds may be rationalised by halide scrambling (cf. X-ray
discussion) or by partial dissociation of the halide trans to
the NHC ligand.[21b,25] In support of the latter, a single
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compound with sharp signals was observed when the spec-
trum was recorded in CD3CN solution, indicating that the
coordinating ability of the solvent is relevant. The
NCH2CH3 signals are diastereotopic and resonate as two
well-resolved multiplets. Halide substitution by a solvent
molecule thus induces enhanced flexibility of the C,E-bi-
dentate ligand, presumably because of the absence of hydro-
gen bonding between the ligand and a metal-bound halide.
While fluxional behaviour of the six-membered metallacy-
cle cannot be excluded, it is worth noting that the sulfido
complexes 7 and 8 display a single set of resonances, despite
the chirality at the sulfur atom.
Metallation of the Imidazolium C2 Position
The availability of a C2–H unit in complexes 5–8 and the
relatively acidic character of this proton, as deduced from
NMR spectroscopy, prompted us to explore the possibility
of constructing dimetallic complexes by metallation of the
C2 position. In order to further stabilise a potentially C2-
bound palladium centre, a second donor group was intro-
duced onto the NHC precursor. The imidazolium salt 9a
(Scheme 3) was prepared directly from 4/5-iodoimidazole
and (bromomethyl)pyridine according to a known pro-
cedure.[26] Subsequent oxidative addition to Pd(dba)2 af-
forded complex 10 as an air- and moisture-stable solid in
60% yield.
Scheme 3. Metallation of 9. Reagents and conditions: Pd(dba)2,
CH2Cl2, r.t., 5 d.
The structure of 10 was unambiguously confirmed by X-
ray crystallography (Figure 2), which revealed the expected
distorted square-planar coordination geometry around the
palladium atom and C,N-bidentate chelation of the ligand.
Similar to 5, the bicyclic ligand assumes a puckered confor-
mation with the imidazolylidene and pyridyl rings twisted
out of the metal coordination plane by about 40°, and the
bite-angle is slightly more acute than 90°. The structure
contains two isomers in an approximately 8:2 ratio due to
halide scrambling. The major isomer contains the iodide
ligand cis with respect to the NHC ligand and reveals close
C–H···X contacts for the imidazolylidene and the pyridyl
heterocycle through C(2)–H···I(1) and C(9)–H···Br(1) inter-
actions, respectively.
In agreement with the NMR analyses of complexes 5–8,
palladation of the precursor 9b to form 10 brings about an
upfield shift of the imidazolylidene C2–H and C5–H proton
signals and a shift of the resonance due to the carbon atom
originally bound to iodide. The chemical shift difference of
the inequivalent methylene groups increased from 0.03 ppm
to 0.23 ppm upon palladation, indicative of a change in
Figure 2. ORTEP representation of 10 (50% probability level, hy-
drogen atoms omitted for clarity). Selected bond lengths [Å] and
angle [°]: Pd(1)–C(1) 1.976(4), Pd(1)–N(3) 2.080(3), C(1)–C(2)
1.363(5), C(1)–Pd(1)–N(3) 86.76(14).
chemical environment due to metal coordination of one pic-
olyl group only. Similarly, the difference in chemical shift of
the two sets of pyridyl protons became more pronounced
and, notably, one set of signals was less sharp. This broad-
ening was also observed in the 13C NMR spectrum and
suggests limited flexibility of one picolyl unit in solution
akin to complex 5. The resonance of the C6–H proton of
the coordinated pyridyl ring is broad and shifted downfield
to δH = 8.89 ppm suggesting that the crystallographically
identified C(9)–H···Br–Pd hydrogen bonding motif persists
in solution as was observed for complex 5.
Reaction of complex 10 or any of the complexes 5–8 with
Ag2O did not produce the desired C2-bound silver–carbene
complexes for use in transmetallation reactions.[27] Direct
metallation with Pd(OAc)2 also proved unsuccessful.[28] Af-
ter 16 h in DMSO at 60 °C, the complexes apparently de-
composed. Attempts to deuterate the C2-bound hydrogen
atom in 7 by using D2O similarly failed, even in the pres-
ence of KOH.[29] Inversion of the metallation sequence was
more successful. Thus, palladation of the C2 position of
the imidazolium chloride 9b, obtained from 9a by halide
exchange, was accomplished by treatment with Ag2O and
subsequent transmetallation using [PdCl2(MeCN)2]. This
procedure cleanly afforded the pincer complex 11 in 60%
yield (Scheme 4). The formation of 11 was confirmed by the
disappearance of the C2–H proton signal in the 1H NMR
spectrum, as well as by an upfield shift of the C5–H proton
signal to δ = 7.82 ppm. No broadening of the imidazolylid-
ene signals was observed in the 13C NMR spectrum, and
the carbene carbon resonance was noted at δC = 151.3 ppm.
The proton and carbon signals due to the picolyl moieties
were also sharp, and chelation therefore seems to be rigid.
The inequivalence of the picolyl NCH2 signals is reflected
by a 0.1 ppm shift difference between the two singlets in the
1H NMR spectrum.
Subsequent exposure of 11 to Pd(dba)2 in the presence
of bipyridine (bpy) under reaction conditions similar to
those used previously resulted in the formation of 12 and
[PdCl2(bpy)] (13) in a 1:0.4 ratio (Scheme 4). This ratio did
not change upon prolonged stirring. Crystallisation
attempts yielded a pure fraction of 13 yet induced signifi-
cant decomposition of 12. The identity of 13 was confirmed
unambiguously by 1H NMR spectroscopy and X-ray crys-
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Scheme 4. Sequential metallation at C2 and C4 to form the dimet-
allic complex 12. Reagents and conditions: (i) Ag2O, DMSO/
CH2Cl2, r.t., 4 d, then [PdCl2(MeCN)2], DMSO/CH2Cl2/MeCN,
2.5 h; (ii) Pd(dba)2, 2,2-bipyridine, DMSO/MeCN, r.t., 2 d.
tallography.[30] Formation of the dinuclear complex 12 is
supported by ESI mass spectrometry, especially through the
characteristic isotope distribution pattern that correlates
well with a dipalladium species. While the instability of
complex 12 precluded its isolation in pure form thus far,
NMR spectra of the crude reaction mixture were informa-
tive. Metallation of the C4 position of 11 led to an upfield
shift of the signal of the C5-bound hydrogen atom from δH
= 7.82 to δH = 7.06 ppm. The NCH2 signals appeared as
two sets of AB doublets at δH = 5.94 and 5.87 ppm (2JH,H
= 15.4 Hz) and at δH = 5.73 and 5.66 ppm (2JH,H =
15.3 Hz). 2D shift-correlation experiments revealed the
presence of five sets of pyridyl signals, one of which was
assigned to the bpy ligand in 13.[30] The remaining four sets
were attributed to the asymmetric bpy ligand and the two
picolyl groups of 12 (Figure 3). The two sets of picolyl sig-
nals remained sharp, suggesting coordination to the C2-
bound rather than to the C4-bound palladium centre. In
agreement with this notion, the change in chemical environ-
Figure 3. Section of the 500 MHz 1H NMR spectrum of the crude
reaction mixture ([D6]DMSO solution) showing 12 and 13 in a
1:0.4 ratio (grey filled circles, grey open circles: py signals; black
filled diamonds: bpy signals of 12; grey filled squares: bpy signals
of 13).
ment upon formation of the dimetallic complex induced
only a slight increase in chemical shift difference compared
with the corresponding shifts in 11.
Conclusions
Abnormal imidazolylidene–palladium(II) complexes
were successfully synthesised by oxidative addition of iodo-
functionalised imidazolium salts to Pd(dba)2. The com-
plexes are air- and moisture-stable and were fully character-
ised by NMR spectroscopy and X-ray crystallography. Dif-
ferent functionalised wingtip groups, ranging from hard
–NEt2 to soft –SPh, were tolerated, and X-ray crystallogra-
phy and NMR spectroscopy provided evidence for chela-
tion in the solid state and also in solution. The asymmetry
of the bidentate ligand renders the trans positions on the
complex electronically inequivalent and may lead to inter-
esting reactivity of the complex. Since the oxidative ad-
dition protocol does not require the protection of the C2
position, a route to dimetallic complexes has been devised.
The generality of the C2 metallation provides vast opportu-
nities for incorporating a range of different transition met-
als into the dimetallic complex, which may be particularly
attractive for redox processes and for exploring synergistic
potentials, e.g. for inducing catalytic tandem transforma-
tions.
Experimental Section
General Comments: 4-Iodoimidazole, 4-iodo-N-isopropylimidazole,
the imidazolium salt 1 and complex 5 were synthesised as reported
previously.[11–13] All other reagents are commercially available and
were used as received. Standard Schlenk techniques were used in
the synthesis of compounds 5–8 and 10–13. Unless otherwise
stated, NMR spectra were recorded at 30 °C with Bruker and Var-
ian spectrometers operating at 400, 500 or 600 MHz (1H NMR)
and 100, 125 or 150 MHz [13C{1H} NMR], respectively. Chemical
shifts (δ in ppm, coupling constants J in Hz) were referenced to
residual solvent resonances. Assignments are based on homo- and
heteronuclear shift-correlation spectroscopy. Elemental analyses
were performed by the Microanalytical Laboratory at the Federal
Institute of Technology in Zurich, Switzerland and at the Univer-
sity College Dublin, Ireland.
Synthesis of 2: 4-Iodo-N-isopropylimidazole (2.2 g, 9.5 mmol), 2-
bromo-N,N-diethylamine hydrobromide (2.5 g, 9.5 mmol) and
NaHCO3 (1.2 g, 14 mmol) were stirred in refluxing EtOH (30 mL)
for 4 d. The colour of the reaction mixture changed from colourless
to yellow. After cooling to room temp., the solvent was removed in
vacuo, and the residue was dissolved in CH2Cl2 (100 mL) and fil-
tered through Celite. The solution was concentrated to 10 mL and
added to Et2O (100 mL) to precipitate the crude product. Tritura-
tion with acetone yielded 2 as a white hygroscopic solid (1.1 g, 26%
yield). 1H NMR ([D6]DMSO, 500 MHz): δ = 9.32 (d, 4JH,H =
1.6 Hz, 1 H, Himi), 8.13 (d, 4JH,H = 1.6 Hz, 1 H, Himi), 4.66 (septet,
3JH,H = 6.7 Hz, 1 H, CHMe2), 4.11 (t, 3JH,H = 6.0 Hz, 2 H,
NCH2CH2N), 2.69 (t, 3JH,H = 6.0 Hz, 2 H, NCH2CH2N), 2.45 (q,
3JH,H = 7.0 Hz, 4 H, NCH2CH3), 1.46 [d, 3JH,H = 6.7 Hz, 6 H,
CH(CH3)2], 0.83 (t, 3JH,H = 7.0 Hz, 6 H, NCH2CH3) ppm. 13C{1H}
NMR ([D6]DMSO, 125 MHz): δ = 137.6, 126.4 (2 Cimi), 80.7
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(Cimi-I), 52.7 (CHMe2) 51.1 (NCH2CH2N), 48.6 (NCH2CH2N),
46.6 (NCH2CH3), 22.2 [CH(CH3)2], 12.0 (NCH2CH3) ppm.
C12H23BrIN3·0.5H2O (425.15): calcd. C 33.90, H 5.69, N 9.88;
found C 34.63, H 5.69, N 9.88.
Synthesis of 3: 4-Iodo-N-isopropylimidazole (0.24 g, 1.0 mmol) and
2-chloroethyl phenyl sulfide (0.3 mL, 2 mmol) were stirred at
120 °C for 16 h. During this period, the reaction mixture changed
colour form light yellow to red. Et2O was added, and the formed
precipitate was isolated by decantation. The crude product was
purified by recrystallisation from MeCN and Et2O to yield 3 as a
light yellow hygroscopic solid (0.36 g, 88% yield). 1H NMR
([D6]DMSO, 500 MHz): δ = 9.45 (d, 4JH,H = 1.6 Hz, 1 H, Himi),
8.03 (d, 4JH,H = 1.6 Hz, 1 H, Himi), 7.39–7.33 (m, 4 H, Haryl), 7.26–
7.21 (m, 1 H, Haryl), 4.56 (septet, 3JH,H = 6.7 Hz, 1 H, CHMe2),
4.32 (t, 3JH,H = 6.6 Hz, 2 H, NCH2CH2N), 3.50 (t, 3JH,H = 6.6 Hz,
2 H, NCH2CH2N), 1.41 [d, 3J H,H = 6.7 Hz, 6 H, CH(CH3)2] ppm.
13C{1H} NMR ([D6]DMSO, 125 MHz): δ = 137.7 (Cimi), 133.9,
129.2, 128.7 (3 Caryl), 126.5 (Cimi), 126.5 (Caryl), 82.2 (Cimi-I),
52.8 (CHMe2) 49.7 (NCH2CH2S), 31.7 (NCH2CH2S), 22.1
[CH(CH3)2] ppm. C14H18ClIN2S·H2O (426.74): calcd. C 39.40, H
4.72, N 6.56; found C 39.39, H 4.36, N 6.27.
Synthesis of 4: 4-Iodo-N-isopropylimidazole (0.24 g, 1.0 mmol) and
2-chloroethyl methyl sulfide (0.2 mL, 2 mmol) were stirred at 60 °C
for 2 h and then at 80 °C for 16 h. The yellowish reaction mixture
was cooled to room temp., and Et2O (5 mL) was added upon which
a white precipitate immediately formed. The mixture was stirred
for 10 min and then left to settle. The formed precipitate was iso-
lated by decantation. The crude product was purified by recrystalli-
sation from warm MeCN to yield 4 as an off-white solid (81 mg,
23% yield). 1H NMR (CDCl3, 360 MHz): δ = 10.88 (s, 1 H, Himi),
7.44 (s, 1 H, Himi), 4.82 (sept, 3JH,H = 6.8 Hz, 1 H, CHMe2), 4.58
(t, 3JH,H = 6.4 Hz, 2 H, NCH2CH2N), 2.98 (t, 3JH,H = 6.4 Hz, 2
H, NCH2CH2N), 2.28 (s, 3 H, SMe), 1.63 [d, 3JH,H = 6.8 Hz, 6 H,
CH(CH3)2] ppm. 13C{1H} NMR (CDCl3, 90 MHz): δ = 139.3,
125.7 (2 Cimi), 80.3 (Cimi-I), 54.0 (CHMe2) 49.3 (NCH2CH2S),
33.8 (NCH2CH2S), 23.1 [CH(CH3)2], 15.8 (SMe) ppm.
C9H16ClIN2S (346.66): calcd. C 31.18, H 4.65, N 8.08; found C
31.31, H 4.73, N 8.01.
Synthesis of 6: A suspension of 2 (0.18 g, 0.39 mmol) in dry CH2Cl2
(15 mL) was cooled to 0 °C and added to Pd(dba)2 (0.23 g,
0.40 mmol). The reaction mixture, which immediately changed col-
our from colourless to deep red, was allowed to reach room temp.
and stirred for 2 d. A yellow precipitate gradually formed. The re-
action mixture was concentrated to 7 mL and filtered through Ce-
lite. The residue was washed with CH2Cl2 and subsequently ex-
tracted with MeCN. The combined MeCN fractions were concen-
trated, and the residue was triturated with Et2O and dried in vacuo
to yield 6 as a yellow solid (38 mg, 18% yield). 1H NMR ([D6]-
DMSO, 500 MHz): δ = 8.90 (s, 1 H, Himi), 7.13 (s, 1 H, Himi), 4.49
(sept, 3JH,H = 6.6 Hz, 1 H, CHMe2), 4.27 (br., 2 H, NCH2), 3.3,
3.0 (br., 4 H, NCH2CH3), 2.8 (br., 2 H, NCH2), 1.40 [d, 3JH,H =
6.6 Hz, 6 H, CH(CH3)2], 1.4 (br., 6 H, NCH2CH3) ppm. 13C{1H}
NMR ([D6]DMSO, 125 MHz): δ = 132.4, 124.6 (br., 2 Cimi), 53.2
(NCH2CH3), 51.9 (NCH2), 51.6 (CHMe2), 46.4 (NCH2), 22.5
[CH(CH3)2], 11.7 (NCH2CH3) ppm; carbene C signal not resolved.
HR-MS (ESI+): calcd. for C12H23IN3Pd [M – Br]+ 441.9971; found
441.9990. C12H23BrIN3Pd·0.25Et2O (541.09): calcd. C 28.86, H
4.75, N 7.77; found C 28.77, H 4.55, N 7.82.
Synthesis of 7: A solution of 3 (0.31 g, 0.76 mmol) in dry DMSO
(10 mL) was added to Pd(dba)2 (0.44 g, 0.76 mmol) and stirred at
room temp. for 2 d. The reaction mixture was filtered through Ce-
lite, and the filtrate was added to a 1:1 mixture of Et2O/CH2Cl2.
The formed precipitate was isolated by centrifugation, washed with
CH2Cl2 and dried in vacuo, thus affording 7 as a yellow solid
(0.12 g, 31% yield). 1H NMR ([D6]DMSO, 500 MHz): δ = 8.89 (s,
1 H, Himi), 8.1–7.7 (m, 2 H, Haryl), 7.55–7.40 (m, 3 H, Haryl), 7.3
(br., 1 H, Himi), 4.52 (sept, 3JH,H = 6.7 Hz, 1 H, CHMe2), 4.3 (br.,
2 H, NCH2), 3.2 (br., 2 H, SCH2), 1.42 [d, 3JH,H = 6.7 Hz, 6 H,
CH(CH3)2] ppm. 13C{1H} NMR ([D6]DMSO, 125 MHz): δ = 133.2
(br., Cimi), 129.7 (br., Caryl), 129.3, 128.8 (2 Caryl), 124.7 (br.,
Cimi), 51.0 (CHMe2), 47.9 (br., NCH2), 36.5 (br., SCH2), 22.5
[CH(CH3)2] ppm; carbene C and quaternary Caryl signals not re-
solved. C14H18ClIN2PdS (515.15): calcd. C 32.64, H 3.52, N 5.44;
found C 32.48, H 3.38, N 5.15.
Synthesis of 8a: A suspension of 4 (0.30 g, 0.87 mmol) and Pd-
(dba)2 (0.50 g, 0.87 mmol) in DMSO (10 mL) were stirred at room
temp. for 1 d. The solution was filtered through Celite and added
to EtOH (10 mL). The crude product was precipitated from the
solution by the addition of Et2O (100 mL) and isolated by centrifu-
gation. Recrystallisation from hot MeCN (30 mL) yielded 8a as a
yellow solid (120 mg, 30% yield). 1H NMR ([D6]DMSO,
500 MHz): δ = 8.86 (s, 1 H, Himi), 7.3 (br., 1 H, Himi), 4.51 (sept,
3JH,H = 6.6 Hz, 1 H, CHMe2), 4.4 (br., 2 H, NCH2), 2.8 (br., 2 H,
SCH2), 2.70 (s, 3 H, SMe), 1.42 [d, 3JH,H = 6.6 Hz, 6 H, CH-
(CH3)2] ppm. 13C{1H} NMR ([D6]DMSO, 125 MHz): δ = 132.6
(Cimi), 129.2 (br., Cimi), 123.0 (br., Cimi-Pd), 50.8 (CHMe2), 47.9
(NCH2), 32.4 (SCH2), 22.4 [CH(CH3)2], 22.0 (SMe) ppm.
C9H16ClIN2PdS (453.08): calcd. C 23.86, H 3.56, N 6.18; found C
23.91, H 3.71, N 6.16.
Synthesis of 8b: Complex 8a (80 mg, 0.18 mmol) and an excess of
NaI (0.75 g) were stirred in acetone (100 mL) at room temp. for
16 h. The solvent was removed in vacuo and the residue redissolved
in hot MeCN (20 mL) and filtered. Cooling of the filtrate to –30 °C
yielded orange crystals of 8b (38 mg, 39% yield). 1H NMR ([D6]-
DMSO, 500 MHz): δ = 8.86 (s, 1 H, Himi), 7.4 (br., 1 H, Himi), 4.50
(sept, 3JH,H = 6.7 Hz, 1 H, CHMe2), 4.4 (br., 2 H, NCH2), 2.8 (br.,
2 H, SCH2), 2.77 (s, 3 H, SMe), 1.41 [d, 3JH,H = 6.7 Hz, 6 H,
CH(CH3)2] ppm. 13C{1H} NMR ([D6]DMSO, 125 MHz): δ = 133.2
(Cimi), 129.2 (Cimi), 51.4 (CHMe2), 48.5 (NCH2), 33.2 (SCH2), 25.1
(SMe), 23.0 [CH(CH3)2] ppm; carbene C signal not resolved.
C9H16I2N2PdS (544.53): calcd. C 19.85, H 2.96, N 5.14; found C
19.4, H 2.82, N 5.00.
Synthesis of 9a: 4-Iodoimidazole (2.9 g, 15 mmol), 2-(bro-
momethyl)pyridine hydrobromide (7.6 g, 30 mmol) and NaHCO3
(3.8 g, 45 mmol) were suspended in EtOH (80 mL) and heated to
reflux for 3 d. The colour of the reaction mixture turned from
colourless to pink within a few minutes. At room temp. the reaction
mixture was filtered and washed with EtOH, and the red solution
was concentrated in vacuo. A precipitate formed, which was iso-
lated by filtration and repeatedly washed with CH2Cl2 and acetone
to yield 9a as an off-white solid (1.7 g, 25% yield). 1H NMR
([D6]DMSO, 500 MHz): δ = 9.59 (d, 4JH,H = 1.4 Hz, 1 H, Himi),
8.59 (d, 3JH,H = 4.8 Hz, 1 H, Hpy), 8.53 (d, 3JH,H = 4.8 Hz, 1 H,
Hpy), 8.05 (d, 4JH,H = 1.4 Hz, 1 H, Himi), 7.94–7.87 (m, 2 H, Hpy),
7.53–7.47 (m, 2 H, Hpy), 7.45–7.37 (m, 2 H, Hpy), 5.64 (s, 2 H,
NCH2), 5.61 (s, 2 H, NCH2) ppm. 13C{1H} NMR ([D6]DMSO,
125 MHz): δ = 153.2, 152.8 (2 Cpy), 149.6, 149.5 (2 Cpy), 140.4
(Cimi), 137.5, 137.3 (2 Cpy), 129.4 (Cimi), 123.7, 123.5 (2 Cpy),
122.5, 122.4 (2 Cpy), 81.0 (C–I), 53.9, 53.4 (2 NCH2) ppm.
C15H14BrIN4 (457.11): calcd. C 39.41, H 3.09, N 12.26; found C
39.16, H 3.13, N 12.02.
Synthesis of 9b: Compound 9a (1.7 g, 3.6 mmol) was dissolved in
MeOH and filtered through a Dowex ion-exchange resin (14
chloride form, 100–200 mesh). After removal of the solvent in
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vacuo, 9b was obtained as a light yellow solid (1.1 g, 72% yield).
1H NMR (CD3OD, 600 MHz): δ = 9.54 (d, 4JH,H = 1.3 Hz, 1 H,
Himi), 8.58 (d, 3JH,H = 4.6 Hz, 1 H, Hpy), 8.52 (d, 3JH,H = 4.6 Hz,
1 H, Hpy), 7.91–7.86 (m, 3 H, Himi, Hpy), 7.59 (d, 3JH,H = 7.8 Hz,
1 H, Hpy), 7.52 (d, 3JH,H = 7.8 Hz, 1 H, Hpy), 7.45–7.37 (m, 2 H,
Hpy), 5.65 (s, 2 H, NCH2), 5.62 (s, 2 H, NCH2) ppm. 13C{1H}
NMR ([D6]DMSO, 125 MHz): δ = 154.0, 153.6 (2 Cpy), 151.0,
150.9 (2 Cpy), 141.4 (t, 1JD,C = 32.8 Hz, Cimi), 139.2, 138.9 (2
Cpy), 131.1 (Cimi), 125.3, 125.0 (2 Cpy), 124.3, 124.0 (2 Cpy),
79.6 (C–I), 55.7, 55.2 (NCH2) ppm. C15H14ClIN4 (412.66): calcd.
C 43.66, H 3.42, N 13.58; found C 43.36, H 3.35, N 13.29.
Synthesis of 10: A suspension of 9a (0.23 g, 0.50 mmol) and
Pd(dba)2 (0.29 g, 0.50 mmol) in dry CH2Cl2 (15 mL) was stirred at
room temp. for 5 d. A yellow precipitate gradually formed. The
reaction mixture was filtered through Celite, and the residue was
washed with CH2Cl2 and cold MeCN. The product was then ex-
tracted from the residue with warm DMSO and added to a 5:1
mixture of Et2O and CH2Cl2. The formed precipitate was isolated
by centrifugation and dried in vacuo as a yellowish solid (168 mg,
60% yield). 1H NMR ([D6]DMSO, 500 MHz): δ = 9.02 (s, 1 H,
Himi), 8.9 (br., 1 H, Hpy), 8.56–8.50 (m, 1 H, Hpy), 8.20–8.08 (m, 1
H, Hpy) 7.88–7.81 (m, 1 H, Hpy), 7.81–7.74 (m, 1 H, Hpy), 7.66–
7.56 (m, 1 H, Hpy), 7.47–7.41 (m, 1 H, Hpy), 7.40–7.33 (m, 1 H,
Hpy), 7.13 (s, 1 H, Himi), 5.65 (s, 2 H, NCH2), 5.42 (s, 2 H, NCH2)
ppm. 13C{1H} NMR ([D6]DMSO, 125 MHz): δ = 154.0, 151.8,
149.6, 140.4 (br), 137.5 (5 Cpy), 134.6, 128.5 (2 Cimi), 125.2,
125.0 (br., 2 Cpy), 123.6, 122.7 (2 Cpy), 53.9 (br., NCH2), 53.4
(NCH2) ppm; carbene C and pyridyl C6 signals not resolved.
C15H14BrIN4Pd·0.5DMSO (602.59): calcd. C 31.89, H 2.84, N
9.30; found C 31.65, H 2.49, N 9.42.
Synthesis of 11: A solution of 9b (0.41 g, 1.0 mmol) in a mixture
of dry CH2Cl2 (35 mL) and DMSO (15 mL) was added to Ag2O
Table 2. Crystallographic data for complexes 6, 7, 8b and 10.
6 7 8b 10
Colour orange yellow yellow, yellow
Shape rod plate plate plate
Crystal size [mm] 0.380.180.13 0.050.030.01 0.200.200.03 0.170.140.03
Empirical formula C12H32BrIN3Pd·C2H6OS C14H18ClIN2PdS C9H16I2N2Pd·C2H6OS C15H14BrIN4Pd
Formula mass 600.67 515.11 622.63 563.51
T [K] 100(2) 100(2) 173(2) 100(2)
Crystal system monoclinic monoclinic monoclinic triclinic
Space group P21/c (# 14) P21/c (# 14) P21/c (# 14) P1¯ (# 2)
Unit cell
a [Å] 12.8889(9) 10.0971(5) 13.1246(16) 8.8721(1)
b [Å] 18.4942(12) 8.5516(4) 8.3281(6) 8.9579(2)
c [Å] 8.6701(6) 19.3799(9) 17.658(2) 10.5343(2)
α [°] 90 90 90 91.309(1)
β [°] 105.135(1) 96.279(4) 105.579(9) 92.488(1)
γ [°] 90 90 90 91.114(1)
V [Å3] 1995.0(2) 1663.35(14) 1859.1(3) 836.04(3)
Z 4 4 4 2
Dcalcd. [g cm–3] 2.000 2.057 2.224 2.239
μ [mm–1] 4.590 26.146 4.539 26.255
Total reflections 47788 8851 23384 23746
Unique reflections 6618 2378 5028 3462
Rint 0.0315 0.0415 0.0615 0.0624
Transmittance range 0.587–0.327 0.461–0.703 0.406–0.201 0.507–0.056
Parameters, restraints 206, 0 184, 0 185, 0 200, 0
R,[a] Rw[b] 0.0375, 0.1032 0.0479, 0.1287 0.0340, 0.0782 0.0287, 0.0808
GOF 1.067 1.044 0.977 1.067
Largest hole, peak –1.606, 2.855 –1.316, 0.823 –1.800, 0.805 –1.269, 1.690
[eÅ–3]
[a] R1 = Σ||Fo| – |Fc||/Σ|Fo| for all I  2σ(I). [b] wR2 = {Σw(Fo2 – Fc2)2/Σ[w(Fo4)]1/2}.
(0.14 g, 0.60 mmol). The reaction mixture was stirred at room
temp. for 4 d protected from light, after which it was filtered and
transferred to a suspension of [PdCl2(MeCN)2] (0.26 g, 1.0 mmol)
in a 1:1 mixture of CH3CN/CH2Cl2 (20 mL). The reaction mixture
immediately became clear and orange, and a white precipitate
started to form slowly, while the solution became yellow. The reac-
tion mixture was stirred for 2.5 h, filtered through Celite, and the
filtrate was concentrated in vacuo. The concentrated solution was
added to a 1:1 mixture of Et2O/CH2Cl2 (50 mL). The product pre-
cipitated as a yellow solid, which was isolated by filtration and
dried in vacuo (330 mg, 60% yield). An analytically pure sample
was obtained by recrystallisation of 11 from CHCl3 and Et2O. 1H
NMR ([D6]DMSO, 600 MHz): δ = 9.41–9.38 (m, 2 H, Hpy), 8.27–
8.22 (m, 2 H, Hpy), 8.14 (d, 3JH,H = 7.6 Hz, 1 H, Hpy) 7.89 (d,
3JH,H = 7.0 Hz, 1 H, Hpy), 7.82 (s, 1 H, Himi), 7.73–7.68 (m, 2 H,
Hpy), 5.71 (s, 2 H, NCH2), 5.61 (s, 2 H, NCH2) ppm. 13C{1H}
NMR ([D6]DMSO, 150 MHz): δ = 155.8, 155.7, 152.5, 152.3 (4
Cpy), 151.3 (Ccarbene), 141.4, 141.3 (Cpy), 127.9 (Cimi), 126.9, 126.6,
125.5, 125.3 (4 Cpy), 75.9 (Cimi-I), 54.6, 53.9 (2 NCH2) ppm.
HR-MS (ESI+): calcd. for C15H13IN4Pd [M – Cl]+ 516.8908; found
516.8906. C15H13Cl2IN4Pd·CHCl3 (672.90): calcd. C 28.56, H 2.10,
N 8.33; found C 28.59, H 1.92, N 8.47.
Synthesis of 12: A suspension of 11 (19 mg, 0.035 mmol), Pd(dba)2
(20 mg, 0.035 mmol) and 2,2-bipyridine (5.5 mg, 0.035 mmol) was
stirred in DMSO (2 mL) at room temp. for 1 d. The reaction mix-
ture was filtered through Celite, and the filtrate was added to a
1:1 mixture of CH2Cl2/Et2O (20 mL). The formed precipitate was
isolated by centrifugation and dried in vacuo. The light yellow
crude product contained 12 and 13 in 2.5:1 molar ratio (20 mg).
1H NMR ([D6]DMSO, 600 MHz): δ = 9.48 (d, 3JH,H = 5.8 Hz, 1
H, HpyA), 9.45 (d, 3JH,H = 5.7 Hz, 1 H HpyB), 9.1 (br., 1 H, Hbpy),
8.69–8.63 (m, 2 H, Hbpy), 8.42–8.37 (m, 1 H, Hbpy), 8.33–8.27 (m,
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1 H, Hbpy), 8.27–8.22 (m, 1 H, HpyA), 8.17–8.12 (m, 1 H, HpyB),
8.1 (br., 1 H, Hbpy), 7.93 (d, 1 H, 3JH,H = 7.6 Hz, HpyA), 7.91–7.87
(m, 1 H, Hbpy), 7.86 (d, 1 H, 3JH,H = 7.6 Hz, HpyB), 7.73–7.63 (m,
1 H, HpyA), 7.68–7.63 (m, 1 H, HpyB), 7.53–7.47 (m, 1 H, Hbpy),
7.06 (s, 1 H, Himi), 5.94 (d, 1 H, 2JH,H = 15.4 Hz, NCH,HA), 5.87
(d, 1 H, 2JH,H = 15.4 Hz, NCH,HA), 5.73 (d, 1 H, 2JH,H = 15.3 Hz,
NCH,HB), 5.66 (d, 1 H, 2JH,H = 15.3 Hz, NCH,HB) ppm. A and
B denote the two picoline residues in 12. HR-MS (ESI+): calcd. for
C25H21Cl2N6Pd2 [M – I]+ 688.9323; found 688.9357.
Structure Determination and Refinement of 6, 7, 8b and 10:[17] Suit-
able single crystals were mounted on a Bruker SMART APEX
CCD diffractometer (6) with a D8 goniometer and a graphite-mon-
ochromator (Mo-Kα radiation, λ = 0.71073 Å), on an Agilent Su-
perNova A diffractometer (7 and 10) with a mirror-monochroma-
tor (Cu-Kα radiation, λ = 1.54184 Å), or on a Stoe Mark II-Image
Plate Diffraction System (8b) with a graphite-monochromator
(Mo-Kα radiation, λ = 0.71073 Å). A semi-empirical absorption
correction was applied for 6 by using SADABS[31] and for 8b by
using MULscanABS as implemented in PLATON.[32] An analytical
numeric absorption correction by using a multifaceted crystal
model was applied for 7 and 10.[33] The structures were solved by
direct methods using the program SHELXS-97[34] and refined by
full-matrix least squares on F2 with SHELXL-97. The hydrogen
atoms were included in calculated positions and treated as riding
atoms by using SHELXL-97 default parameters. All non-hydrogen
atoms were refined anisotropically. Crystals of complex 6 contained
one DMSO molecule per complex molecule. Crystals of 8b con-
tained one disordered DMSO molecule per asymmetric unit, which
was refined with occupancies of 0.5 for all participating atoms. In
6, 7 and 10 the iodide and bromide (7 and 10) and the iodide and
chloride (6) were partially occupied. The major component con-
tained the iodide ligand cis to the carbene with a site occupation
factor of 0.708(3) in 6, 0.556(3) in 7 and 0.778(3) in 10. The minor
component contained the iodide trans to the carbene with a site
occupation factor of 0.292(3) in 6, 0.444(3) in 7 and 0.222(3) in 10.
The sum of the site occupation factors of the major and minor
components were constrained to be 1. Further details on data col-
lection and refinement are summarised in Table 2. CCDC-843008, -
843009, -843010, -843011, and -843012 for complexes 6, 7, 8a, 8b,
and 10, respectively, contain the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
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